Snowball logo
logo
NZM2

NOVOZYMES -B-

NZM2 β€’ MU
€55.54€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
269.1316.82,402.23,833.54,157.64,212
COGS
113.9143.91,097.42,0241,916.11,879.7
Gross Profit
155.2172.81,304.81,809.52,241.52,332.3
Operating Expenses & Income
Operating Income
69.9179.91610.9659882.6956.7
Total Operating Expenses
199.1236.91,791.33,174.53,2753,255.3
R&D Expenses
36.1536.11270.7413.2463.8466.1
Selling General & Admin Expenses
50.358.17446.1765.5911.8927.1
Earnings from Continuing Operations
Interest Expense
(1.835573)(1.840796)(23.1)(76.4)(68.3)-
Interest Income
0.3239250.3248461226.921-
Income Tax Expense
------
Net Income
Net Income
56.6166.34405.9305.8583.6644.7
Supplemental
EBIT
------
EBITDA
728.4822.3----
In millions of EUR, except % and values per 1 share